CLINICAL TRIALS PROFILE FOR ACETAMINOPHEN; BUTALBITAL; CAFFEINE
✉ Email this page to a colleague
All Clinical Trials for ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00573170 ↗ | TREXIMET® Versus Butalbital-containing Combination Medications for the Acute Treatment of Migraine in Adults | Completed | GlaxoSmithKline | Phase 3 | 2008-02-01 | Study TRX109011/TRX109013, A Randomized, Double-blind, Double-dummy, Placebo-controlled, Crossover Study to Evaluate the Efficacy of TREXIMET® (Sumatriptan + Naproxen Sodium) versus Butalbital-containing Combination Medications (BCM) for the Acute Treatment of Migraine when administered during the Moderate-Severe Pain Phase of the Migraine (Studies 1 and 2 of 2) |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Condition Name
Clinical Trial Locations for ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Trials by Country
Clinical Trial Progress for ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Clinical Trial Phase
Clinical Trial Sponsors for ACETAMINOPHEN; BUTALBITAL; CAFFEINE
Sponsor Name